Discontinuation report Metastron
| Report ID | 63929 |
| Drug Identification Number | |
| Brand name | Metastron |
| Common or Proper name | Strontium [89Sr] Chloride |
| Company Name | GE HEALTHCARE CANADA INC |
| Market Status | |
| Active Ingredient(s) | Strontium [89Sr] Chloride |
| Strength(s) | 37 MBq/mL |
| Dosage form(s) | Solution |
| Route of administration | IV |
| Packaging size | single glass vial |
| ATC code | V10BX |
| ATC description | Pain Palliation Bone Seeking Agents |
| Reason for discontinuation | Business reasons |
| Anticipated discontinuation date | |
| Actual discontinuation date | 2019-01-31 |
| Remaining supply date | 2019-01-31 |
| Discontinuation status | Discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 1919 MINNESOTA COURT MISSISSAUGA, ONTARIO CANADA L5N 0C9 |
| Company contact information | 800-387-7146 canadainfo@ge.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v7 | 2019-02-01 | French | Compare |
| v6 | 2019-02-01 | English | Compare |
| v5 | 2018-12-06 | French | Compare |
| v4 | 2018-12-06 | English | Compare |
| v3 | 2018-10-12 | French | Compare |
| v2 | 2018-10-12 | English | Compare |
| v1 | 2018-10-12 | English | Compare |
Showing 1 to 7 of 7